Booz Allen Hamilton
BAH
$76.36
-3.15%
Booz Allen Hamilton Holding Corporation is a leading management and technology consulting firm that provides advanced analytics, AI, cybersecurity, and engineering solutions primarily to U.S. federal government agencies, with a growing commercial and international presence. As a premier defense and intelligence contractor, it holds a distinct competitive position as a trusted partner for national security missions, leveraging deep domain expertise and a highly cleared workforce. The current investor narrative centers on the company's strategic pivot toward AI-driven defense technologies, which has been bolstered by recent Pentagon budget reallocations and a strong earnings beat that underscored its operational resilience. However, the stock remains under pressure from broader market concerns about government spending and valuation reset, creating a debate between near-term headwinds and long-term growth catalysts.…
BAH
Booz Allen Hamilton
$76.36
Related headlines
Investment Opinion: Should I buy BAH Today?
Based on the analysis, BAH is rated a Hold. The stock offers a compelling valuation at 11.3x trailing PE, but this is offset by declining revenue and high leverage. The average analyst target of $85.58 implies a modest 10.5% upside, which does not provide a sufficient margin of safety given the risks. The recent earnings beat and AI-driven defense spending provide a potential catalyst, but the lack of analyst upgrades and persistent underperformance warrant caution.
Sign up to view all
BAH 12-Month Price Forecast
The AI assessment is neutral, reflecting a balance between deep value and operational challenges. The stock's low PE and high ROE suggest it is undervalued, but the negative revenue growth and high leverage temper enthusiasm. The recent earnings beat and AI catalyst provide upside potential, but the lack of analyst upgrades and persistent underperformance keep us cautious. We would upgrade to bullish if revenue growth turns positive and the stock breaks above its 50-day moving average, or downgrade to bearish if revenue decline accelerates and debt levels rise further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booz Allen Hamilton's 12-month outlook, with a consensus price target around $85.58 and implied upside of +12.1% versus the current price.
Average Target
$85.58
0 analysts
Implied Upside
+12.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$68 - $140
Analyst target range
The target price range spans from a low of $68.00 to a high of $140.00, representing a wide spread of 106% from low to high. The low target implies a potential downside of 12.2% from the current price, likely reflecting concerns about continued revenue contraction and margin pressure. The high target suggests a substantial upside of 80.8%, which would require a significant re-rating and acceleration in growth, possibly driven by AI-related defense contracts. The wide range indicates high uncertainty among analysts about the company's future trajectory, with some seeing a deep value opportunity and others anticipating further deterioration. The recent institutional ratings show a mix of holds and neutral stances, with no major upgrades, reinforcing the cautious outlook.
Bulls vs Bears: BAH Investment Factors
Booz Allen Hamilton presents a classic value-versus-growth dilemma. On the bull side, the stock trades at a deeply discounted 11.3x trailing PE, boasts a stellar 77% ROE, and is positioned to benefit from the Pentagon's AI pivot, which could reignite growth. On the bear side, revenue is contracting, the balance sheet is highly leveraged, and the stock has badly underperformed the market, reflecting persistent operational and sentiment headwinds. Currently, the bear case has stronger evidence due to the confirmed revenue decline and high debt, but the recent earnings beat and AI catalyst provide a credible path to recovery. The most important tension is whether the revenue decline is a temporary budget timing issue or a structural loss of market share; this resolution will determine if the stock is a deep value opportunity or a value trap.
Bullish
- Deep value at 11.3x trailing PE: BAH trades at a trailing PE of 11.29x, a significant discount to the broader consulting industry and its own historical average. This valuation implies the market is pricing in continued deterioration, but the recent earnings beat suggests the pessimism may be overdone.
- Strong earnings beat in Q4 FY2026: Q4 FY2026 EPS came in at $1.69, beating expectations, despite a 6.44% revenue decline. The company's ability to maintain profitability in a challenging environment demonstrates operational resilience and cost discipline.
- Pentagon AI pivot as growth catalyst: The DoD's aggressive reallocation towards AI-driven autonomous systems is creating a long-term, high-margin revenue stream for defense contractors. BAH's expertise in AI and cybersecurity positions it to capture a significant share of this growing budget.
- High ROE of 77%: Booz Allen's return on equity is an exceptional 77.01%, indicating highly efficient use of shareholder capital. This is a testament to its strong franchise and pricing power, even in a period of revenue contraction.
Bearish
- Revenue declining 6.4% YoY: Q4 FY2026 revenue fell 6.44% year-over-year to $2.783 billion, marking a reversal from earlier quarters. This negative growth trend is a key concern, as it suggests the core federal market is facing headwinds from tighter budgets and project timing.
- High debt-to-equity of 3.73x: BAH's debt-to-equity ratio stands at 3.73x, indicating a highly leveraged balance sheet. This amplifies financial risk, especially in a rising interest rate environment, and could constrain future growth investments.
- Underperforming S&P 500 by 48.7%: Over the past year, BAH has declined 28.38% while the S&P 500 gained 20.37%, resulting in a relative underperformance of 48.75 percentage points. This persistent weakness reflects a loss of investor confidence and a potential sector rotation away from defense.
- Analyst consensus is Hold: With a recommendation mean of 2.86 (Hold) and no major upgrades, analysts remain cautious. The average target price of $85.58 implies only 10.5% upside, which is modest given the risks.
BAH Technical Analysis
Booz Allen Hamilton's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -28.38%, significantly underperforming the S&P 500's +20.37% gain. The current price of $77.46 sits at approximately 28% of its 52-week range (between $59.50 low and $112.22 high), indicating the stock is trading near the lower end of its yearly band. This positioning suggests a potential value opportunity, but also reflects persistent selling pressure and a lack of sustained buying interest, as the stock has failed to reclaim its previous highs.
Beta
0.35
0.35x market volatility
Max Drawdown
-48.5%
Largest decline past year
52-Week Range
$60-$112
Price range past year
Annual Return
-30.1%
Cumulative gain past year
| Period | BAH Return | S&P 500 |
|---|---|---|
| 1m | +19.6% | +1.9% |
| 3m | -2.9% | +2.3% |
| 6m | -1.1% | +10.6% |
| 1y | -30.1% | +19.5% |
| ytd | -10.0% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAH Fundamental Analysis
Booz Allen's revenue trajectory has turned negative, with the most recent quarter (Q4 FY2026, ending March 31, 2026) reporting $2.783 billion, a 6.44% year-over-year decline from $2.975 billion in the prior-year quarter. This marks a reversal from the earlier quarters of FY2026, where revenue grew modestly (Q1: $2.924B, Q2: $2.89B, Q3: $2.62B), indicating a deceleration that accelerated into the fiscal year-end. The decline was driven by a mix shift toward cost-reimbursable contracts (which accounted for $1.601B of revenue) and a reduction in fixed-price and time-and-materials work, reflecting tighter government budgets and project timing. This negative growth trend is a key concern for investors, as it suggests the company's core federal market is facing headwinds.
Quarterly Revenue
$2.8B
2026-03
Revenue YoY Growth
-6.4%
YoY Comparison
Gross Margin
20.9%
Latest Quarter
Free Cash Flow
$951000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAH Overvalued?
Given that Booz Allen is profitable, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE stands at 11.29x, while the forward PE is slightly higher at 11.52x, indicating that the market expects earnings to remain relatively stable. The narrow gap between trailing and forward multiples suggests limited growth expectations, which aligns with the recent revenue decline. Compared to the broader consulting industry, which typically trades at higher multiples, Booz Allen's PE is at a significant discount, reflecting its current growth challenges and perceived risk.
PE
11.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Booz Allen's most pressing risk is its high leverage, with a debt-to-equity ratio of 3.73x, which amplifies vulnerability to rising interest rates and could strain cash flows. The company's revenue decline of 6.44% YoY in Q4 FY2026 signals weakening demand, and if this trend persists, it could pressure margins and lead to earnings downgrades. Additionally, the negative PEG ratio of -2.22 indicates that the low PE is not supported by growth, making the stock potentially overvalued on a forward basis. The company's operating margin of 9.75% is relatively thin, leaving limited room for cost absorption if revenue continues to fall.
FAQ
The key risks for BAH are: 1) Financial risk from high leverage (debt-to-equity of 3.73x), which could strain cash flows if interest rates rise. 2) Operational risk from the 6.44% revenue decline, which could persist if government budgets remain tight. 3) Market risk from the stock's underperformance (down 28.38% over the past year) and potential sector rotation away from defense. 4) Company-specific risk from contract concentration in the U.S. federal government, which is subject to political and budgetary uncertainties. The most severe risk is a continued revenue contraction leading to a de-rating, potentially pushing the stock to its 52-week low of $59.50, a 23% downside from current levels.
The 12-month forecast for BAH is mixed. In the base case (50% probability), the stock is expected to trade around the average analyst target of $85.58, implying a 10.5% upside. In the bull case (25% probability), the stock could reach $100-$140 if the AI pivot drives a re-rating. In the bear case (25% probability), the stock could fall to $59-$68 if revenue decline continues. The most likely scenario is the base case, where revenue stabilizes and the stock recovers modestly. Key assumptions include stable government spending and successful execution of the AI strategy.
BAH is undervalued relative to its own history and the broader consulting industry. Its trailing PE of 11.29x is significantly below the industry average of around 20x, and its PS ratio of 0.86x is also low. However, the market is pricing in the recent revenue decline and high leverage, which justifies some discount. The negative PEG ratio of -2.22 suggests that the low PE is not supported by growth, indicating that the stock could be a value trap if earnings continue to fall. Overall, the valuation is attractive for a company with BAH's franchise, but it reflects the market's skepticism about its near-term prospects.
BAH is a good buy for investors with a long-term horizon and a tolerance for risk, given its deep value at 11.3x trailing PE and a 10.5% upside to the average analyst target of $85.58. The recent earnings beat and the Pentagon's AI pivot provide a potential catalyst for growth. However, the stock is not without risks, including a 6.44% revenue decline and a high debt-to-equity ratio of 3.73x. For those seeking a defensive, income-oriented stock, the 2.87% dividend yield offers some support. Overall, it is a speculative buy for value investors, but a Hold for those seeking stability.
BAH is more suitable for long-term investment, given its current challenges and the potential for a multi-year recovery driven by AI. The stock's beta of 0.354 indicates low volatility relative to the market, making it less attractive for short-term traders seeking quick gains. The dividend yield of 2.87% provides some income while waiting for a turnaround. However, the negative revenue growth and high debt suggest that the stock could remain under pressure in the short term. A minimum holding period of 3-5 years is recommended to allow the AI strategy to materialize and for the company to deleverage.